VAMP2 and epilepsy: Individuals 1–3, carrying de novo non-synonymous variants affecting the C terminus of the VAMP2 SNARE motif (residues 75, 77, and 78), presented a severe neurological phenotype with motor impairment (and inability to walk), central visual deficits, hyperkinetic movements, and, in two of them, epilepsy starting in infancy.